BlogZone Get the app
Health

Stopping Ozempic may raise heart attack and stroke risk

A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.

BlogZone shows headlines and summaries from public news feeds. The full story is published by ScienceDaily Health.

Read the full story at ScienceDaily Health →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Health